Nanocarriers for Targeted Cancer Therapy in Personalised Nanomedicine
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".
Deadline for manuscript submissions: 25 April 2026 | Viewed by 103
Special Issue Editors
Interests: nanomedicine; drug delivery; scanning force microscopy; cytomechanics; nanocarriers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue highlights the development and use of nanocarriers for targeted therapies in personalised medicine. Innovative and precision-based strategies for cancer treatment, involving customised nanovectors, play a crucial role in addressing what is often referred to as the ‘disease of the century’. In this scenario, personalised nanomedicine is an emerging and inherently interdisciplinary field, promoting the development of next-generation nano-tools for targeted therapy and diagnosis, such as nanoparticles, nanocapsules, and nanomicelles. The publication of original research articles and reviews in this Special Issue will contribute to advancing scientific knowledge in personalised nanomedicine and support the clinical translation of nanocarrier-based approaches in oncology.
Prof. Dr. Stefano Leporatti
Dr. Francesca Persano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanocarriers
- nanoparticles
- nanomedicine
- cancer therapy
- personalised medicine
- drug delivery
- target therapy
- ligand-mediated targeting
- theranostics
- multifunctional nanoplatforms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
